NEW YORK (GenomeWeb) – Sequenom reported after the close of the market on Tuesday that its diagnostic revenues in the second quarter increased 62 percent year over year.

For the three months ended June 30, the San Diego-based company pulled in $39.8 million, all from its Sequenom Center for Molecular Medicine business, compared to diagnostic revenues of $24.5 million in Q2 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.